NASDAQ · CV
CapsoVision, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for CV: Nov 12, 2026
CapsoVision, Inc. Common Stock is estimated to report earnings on 11/12/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.15. The reported EPS for the same quarter last year was $-0.17.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.15 | $-0.15 | $-0.15 | 1 |
| Dec 2026 | $-0.11 | $-0.11 | $-0.11 | 1 |
| Mar 2027 | $-0.13 | $-0.13 | $-0.13 | 1 |
| Jun 2027 | $-0.12 | $-0.12 | $-0.12 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
MarketBeat · RTTNews · NASDAQ.com · Fintel- MarketBeat · Oct 24, 4:02 AM EDTCapsoVision Maps AI Capsule Push Into Colon, Pancreatic Cancer Screening3 Under-the-Radar Cybersecurity Stocks With Major Upside PotentialCapsoVision (NASDAQ:CV) outlined its strategy to expand capsule endoscopy technology beyond its current small-bowel business into colon, pancreatic and esophageal cancer screening applications, highlighting its art
- RTTNews · Oct 2, 12:13 PM EDTWeekly Buzz: EW, ABBV, MIRM Score FDA Wins, AZN, NVO Strike Deals; LLY, KOD Report Data(RTTNews) – The week brought a fresh round of developments across the biotech and pharma landscape, with companies advancing new therapies through regulatory milestones, clinical studies, strategic deals and corporate activity. Key updates spanned oncology, rare diseases, cardiov
- RTTNews · Sep 28, 12:11 PM EDTCapsoVision's AI Highlights Receives FDA Clearance For CapsoCam Plus(RTTNews) – CapsoVision, Inc. (CV) announced that its AI Highlights assisted reading tool for the CapsoCam Plus capsule endoscopy system received clearance from the U.S. Food and Drug Administration (FDA) on September 25, 2026.
- RTTNews · Sep 28, 9:41 AM EDTCapsoVision Wins FDA Clearance For AI Highlights Tool(RTTNews) – Monday, CapsoVision, Inc. (CV) announced that the U.S. Food and Drug Administration has granted clearance for AI Highlights, its AI-assisted reading tool for the CapsoCam Plus system, designed to support capsule endoscopy review without the need for a separate AI plat
- NASDAQ.com · Sep 25, 4:24 PM EDTAfter Hours Most Active for Sep 25, 2026 : FTXN, ABUS, FTXH, CMCSA, NVDA, CSCO, JPM, BMNR, EQT, CNP, PFE, CVSThe NASDAQ 100 After Hours Indicator is up 5.94 to 30,614.08. The total After hours volume is currently 139,531,265 shares traded.The following are the most active stocks for the after hours session: First Trust Nasdaq Oil & Gas ETF (FTXN) is -0.12 at $38.48, with 20,767,281
- MarketBeat · Aug 13, 7:04 PM EDTCapsoVision Q2 Earnings Call Highlights3 Under-the-Radar Cybersecurity Stocks With Major Upside PotentialCapsoVision (NASDAQ:CV) reported second-quarter revenue growth as sales of its CapsoCam Plus capsule endoscopy system increased, while the company advanced its artificial intelligence software rollout and developme
- RTTNews · Aug 4, 4:02 AM EDTCRISPR Q2 Net Loss Narrows; Multiple Clinical Updates For Gene Therapy Pipeline Ahead In H2 2026(RTTNews) – CRISPR Therapeutics (CRSP), a gene editing company, reported financial results for the second quarter of 2026, reflecting a narrower net loss. In addition, the company provided an update on the clinical pipeline.
- RTTNews · Aug 4, 1:58 AM EDTCapsoVision Unveils AI Highlights For Capsule Endoscopy Studies Of CapsoCam Plus System(RTTNews) – CapsoVision, Inc. (CV), a commercial-stage medical technology company, announced the launch of AI Highlights for the CapsoCam Plus system to support physician review of small bowel capsule endoscopy studies.
- MarketBeat · May 14, 7:10 PM EDTCapsoVision Q1 Earnings Call Highlights3 Under-the-Radar Cybersecurity Stocks With Major Upside PotentialCapsoVision (NASDAQ:CV) reported steady first-quarter revenue and said it continues to advance artificial intelligence and capsule endoscopy programs aimed at expanding the use of its gastrointestinal imaging platf
- NASDAQ.com · May 11, 7:59 PM EDTAfter Hours Most Active for May 11, 2026 : HIMS, NVDA, INTC, ASTS, MSFT, GME, CRCL, ACHR, IONQ, AAPL, IREN, CVXThe NASDAQ 100 After Hours Indicator is down -29.89 to 29,034.91. The total After hours volume is currently 310,938,369 shares traded.The following are the most active stocks for the after hours session: Hims & Hers Health, Inc. (HIMS) is -4.11 at $25.03, with 17,538,415 sha
- Fintel · Mar 27, 9:06 PM EDTCapsoVision (CV) Price Target Increased by 19.05% to 12.75The average one-year price target for CapsoVision (NasdaqCM:CV) has been revised to $12.75 / share. This is an increase of 19.05% from the prior estimate of $10.71 dated February 21, 2026. The price target is an average of many targets provided by analysts. Th
- RTTNews · Mar 26, 3:03 PM EDTCapsoVision Q4 25 Earnings Conference Call At 4:30 PM ET(RTTNews) – CapsoVision, Inc (CV) will host a conference call at 4:30 PM ET on March 26, 2026, to discuss Q4 25 earnings results.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for CapsoVision, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.